Cytokinetics Granted Orphan Drug Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis

NEXT STORY
Daré Bioscience Announces FDA Clearance of IND Application for DARE-BV1 for Bacterial Vaginosis to Commence Pivotal Phase 3 Clinical Study
PREV STORY
GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aphios is Developing a Platform for the Delivery of siRNA-based Therapeutics Towards an HIV Cure

WOBURN, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it ...

author_avatar
NASDAQ Market News

Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

author_avatar
NASDAQ Market News

At 6.0% CAGR, Ultrasound Devices Market Expected to Grow USD 9.50 Bn by 2021

Sarasota, FL, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a ...

author_avatar
NASDAQ Market News